• The document is an intimation of an analyst/investor meet titled "EI Live @ LTTS," scheduled to be held on June 30, 2026.
  • The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and is a continuation of a previous letter dated June 25, 2026.
  • A presentation deck for the meet was enclosed with this intimation and has been uploaded to the company's website at www.ltts.com.
  • The presentation outlines the company's Engineering Intelligence (EI) platform and strategy, focusing on integrating AI into product design and manufacturing.
  • It highlights four lenses of EI: Engineering AI, Agentic AI, Physical AI, and Industrial AI.
  • The presentation details applications across various verticals, including Mobility, Sustainability, Tech, Software & AI Engineering, Digital Manufacturing, and Embedded Engineering.
  • It discloses that the company has filed 151+ patents in AI, with breakdowns including 45 in Machine Learning, 35 in Image Processing, and 55 in Natural Language Processing.
  • Several proprietary AI solutions and tools are listed, including AiKno, AiCE, AnnotAI, EvQUAL, Chest-r AI, Nouvis, AiTest, GEN-IQ, and MICRO SLM, with their launch years ranging from 2017 to 2024.
  • The launch of a new platform, "Ainfonix," an AI-powered Document Intelligence Platform for Process Industries, is announced.
  • Multiple demos are listed for showcase, including MIT AI Readiness Index, PLxAI, AINexus, SDVoult.AI, an AI-based Bronchoscopy solution, Digital Surgery Assist, QAssure.ai, and an Integrated Agentic Development & Testing platform.
  • Additional showcased demos include Agentic IQ, Quantum Sprint, RevAI, EnergiSensEI, Lights Out Factory, Asset Reliability Center, Asset Health Framework, a Sima.AI based Worker Safety solution, and TrackEi.
  • The company is recognized as a Great Place to Work® in Japan and the USA for the period APR 2025-APR 2026.

Additional Notes Section

  • The document includes a comprehensive disclaimer stating that the presentation is for general information, contains forward-looking statements, and does not constitute an offer for securities.
  • The presentation was enclosed as an attachment to the regulatory filing.
  • No specific financial data, quarterly results, or management guidance were disclosed in this particular announcement.